Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-02

Clinical Trial Update: Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain [Phase 4]

View source ↗

Summary

Phase 4 study evaluating rotigotine for pain related to Parkinson's disease; results were posted after completion in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Advanced Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-12-02